• DOI:10.1007/s00259-016-3357-x
Corpus ID: 23005709

PET/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma

@article{Janssen2016PETCTC6,
  title={PET/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma},
  author={Ingo Janssen and Clara C. Chen and Corina M. Millo and A. Ling and D. Taieb and Frank I. Lin and Karen T. Adams and Katherine I. Wolf and P. Herscovitch and Antonio T. Fojo and I. Buchmann and Electron Kebebew and K. Pacak},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2016},
  volume={43},
  pages={1784-1791}
}

Ingo Janssen, Clara C. Chen, +10 authors K. Pacak

Published 2016

Medicine

European Journal of Nuclear Medicine and Molecular Imaging

PurposePheochromocytomas/paragangliomas (PPGLs) and their metastases are tumors that predominantly express somatostatin receptor 2 (SSR2. [...] Key Method The purpose of this study was to evaluate the utility of 68Ga-DOTATATE in comparison with other specific and nonspecific radiopharmaceuticals recommended in the current guidelines for the localization of metastatic sporadic PPGL by PET/CT.MethodsThis prospective study included 22 patients (15 men, 7 women; aged 50.0 ± 13.9 years) with confirmed metastatic…Expand Abstract

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed